Predictive Utility of a Short-term Improvement in Objectively Measured Physical Activity in Rheumatoid Arthritis (PUSIPA)
Conditions: Rheumatoid Arthritis; Fibromyalgia, Secondary; Fatigue; Physical Inactivity Sponsors: Hospital of South West Jutland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Comparison of RA TKA Systems: MAKO vs VELYS
Conditions: Knee Osteoarthritis; Knee Arthritis; Knee Disease Interventions: Device: Stryker Triathlon with MAKO Robotic-Arm; Device: DePuy Attune with VELYS Robotic-Assistance Sponsors: Southeast Orthopedic Specialists; DePuy Orthopaedics; Stryker Orthopaedics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Presence and Comparison of Sarcopenia in Early Rheumatoid Arthritis and Rheumatoid Arthritis
Conditions: Sarcopenia Sponsors: Kayseri City Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)
Conditions: Polymyalgia Rheumatica Interventions: Drug: Prednisolone; Drug: SPI-62 Sponsors: Sparrow Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Phase 3 Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Interventions: Drug: LNK01001; Drug: Placebo Sponsors: Lynk Pharmaceuticals Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Psoriasis Interventions: Drug: Silymarin; Drug: Placebo Sponsors: Phramongkutklao College of Medicine and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
A Study to Investigate the Pharmacokinetic/Pharmacodynamic Characteristics of IBI128(A New Xanthine Oxidase Inhibitor)
Conditions: Gout Arthritis Interventions: Drug: dose-5 group; Drug: dose-1 group; Drug: dose-2 group; Drug: dose-4 group; Drug: dose-3 group Sponsors: Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Defining Stress REsilience And Mindfulness Effects in Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid Interventions: Behavioral: Mindfulness Program Sponsors: University of California, San Francisco; National Center for Complementary and Integrative Health (NCCIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Treatment of Topical Ketorolac Gel in Acute Gouty Flare
Conditions: Acute Gouty Arthritis; Acute Pain; Gout Flare Interventions: Drug: Ketorolac Tromethamine 15 MG/ML; Drug: Ketorolac Tromethamine Sponsors: Novilla Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC)
Conditions: Telemedicine; Telehealth; eHealth; Rheumatic Diseases; Arthritis, Rheumatoid; Spondylarthritis Interventions: Device: IMIDOC Sponsors: Instituto de Investigaci ón Hospital Universitario La Paz Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.
Conditions: Gout Arthritis Interventions: Drug: Recombinant Anti-IL-1 β Humanized Monoclonal Antibody Injection 100 mg; Drug: Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg; Drug: Colchicine 0.5 mg Sponsors: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Boutonniere Deformity Effectiveness of Thermoplastic and Fabricated Orthoses
Conditions: Orthotic Devices Interventions: Device: Thermoplastic orthosis Sponsors: Magdalena Kolasi ńska; National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia
Conditions: Pain, Chronic; Dementia, Mild; Mobility Limitation; Physical Disability; Osteo Arthritis Knee; Mild Cognitive Impairment Interventions: Behavioral: Tailored Physical Activity Program Sponsors: Drexel University; National Institute on Aging (NIA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Robotic Assisted Knee Arthroplasty - Retain the Anterior Cruciate Ligament or Not
Conditions: Arthritis Knee; Arthroplasty; Gait Analysis Interventions: Device: Journey II CR; Device: Journey II XR Sponsors: St. Olavs Hospital; Smith& Nephew, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Hand Exercises in Psoriatic Arthritis
Conditions: Psoriatic Arthritis; Hand Rheumatism Interventions: Other: Hand exercises Sponsors: Akdeniz University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
